TMS Early Intervention After Trauma to Boost Resilience
Official title: PREVENT Study: Promoting Resilience Via Early Neurostimulation After Trauma
Run by Emory University · NCT07568145 · Data updated 2026-11-12
A short brain-stimulation treatment (TMS) is tried shortly after a traumatic event to see if it helps prevent long-term PTSD and depression in people 18–65.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Emory University Academic / other |
| Locations | 2 sites (Atlanta, Georgia and 1 other locations) |
| Status | Recruiting |
| Started | June 18, 2026 |
| Main results expected | March 2028 |
| Study ends | March 2028 |
| Registry record updated | September 8, 2026 |
| Trial ID | NCT07568145 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18–65 who recently experienced trauma (within 2 weeks) and have high acute PTSD symptoms but low lifetime PTSD burden.
✕Probably not a fit
Individuals with ongoing high suicide risk or unstable medication changes may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study tests Transcranial Magnetic Stimulation (TMS) as an early intervention after a traumatic event. Participants are adults who recently experienced trauma and have higher PTSD symptoms but no prior full PTSD from earlier traumas. They are randomly assigned to active TMS or a sham procedure to see if brain stimulation changes neural reactivity related to threat and reduces the chance of chronic PTSD. The approach focuses on the weeks following trauma, a critical window where early treatment may improve outcomes. The study is conducted at Grady Memorial Hospital and Emory Brain Health Center in Atlanta, with Emory University as the lead sponsor and NIMH collaboration.
Why it matters
Potential benefit: If successful, participants may experience reduced risk of developing chronic PTSD and related symptoms.
How similar studies have gone: Earlier studies in other settings suggest brain stimulation can modulate fear and threat processing, but this early-post-trauma application is exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women 18-65 years of age. (Assessed via self-reported and medical record-based Date of Birth) * Trauma-exposed within the last 2 weeks (Endorsement of having experienced an event that could have caused death, serious injury, or sexual violence) * High initial symptoms of PTSD related to the index trauma - PCL-5 \>30 AND at least 2 symptoms of hyperarousal. * Low symptoms of PTSD related to a previous lifetime trauma - PCL-5\<31AND does not meet for all four DSM-5 clusters. * Participants may be on psychotropic medication, including antidepressants, antipsychotics, benzodiazepines and anticonvulsants, but the dosage of the medication must be stable for at least 6 weeks and not change during the course of the study (Assessed via self-report during the screening phone call). * Capable and willing to provide informed consent. Exclusion Criteria: * Having active suicidal intent or plan, or in the clinician's opinion, is likely to attempt suicide within the next six months. (Assessed via the Patient Health Questionnaire-9 (PHQ-9) during the screening phone call) * Lifetime diagnosis of psychotic disorder or bipolar disorder per psychiatric screener. (Assessed via self-report during the screening phone call) * Diagnosed with the following conditions: a neurological disorder, including a history of seizures, cerebrovascular disease, primary or secondary tumors in the central nervous system (CNS), stroke, cerebral aneurysm or movement disorder or any lifetime history of loss of consciousness for more than 5 minutes due to head injury (Assessed via self-report during the screening phone call) * History of cranial surgery, metallic particles in the eye or head (exclusive of mouth), implanted cardiac pacemaker or any intracardiac lines, implanted neurostimulators, intracranial implants (e.g., aneurysm clips, shunts, stimulators, cochlear implants, or electrodes), or implanted medical pumps. (Assessed via self-report during the screening phone call) * For women, being pregnant. (Assessed via self-report during the screening phone call, the medical record, and cycling females will undergo a pregnancy test at TMS Day 1)
Where it's running
-
Grady Memorial Hospital
Atlanta, Georgia, United States Recruiting -
Emory Brain Health Center
Atlanta, Georgia, United States Recruiting
Study contacts
- Principal investigator: Sanne van Rooij, PhD — Emory University
- Study coordinator: Sanne van Rooij, PhD
- Email: sanne.van.rooij@emory.edu
- Phone: 404-251-8926
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Trauma-focused group therapy for adults with trauma symptoms in primary care
A group-based trauma therapy delivered in primary care to see if it helps adults with trauma-related symptoms more than usual care.
-
SMART treatment for youth with complex trauma
This trial tests whether Sensory Motor Arousal Regulation Treatment (SMART) helps kids aged 7–17 with developmental trauma more than usual therapy.
-
Understanding brain changes during therapy for adolescent PTSD
This study is trying to see how trauma-focused therapy changes the brains of teenagers with PTSD to help improve their treatment.
-
Online therapy for public safety personnel with mental health issues
This study is testing an online therapy program to see if it can help Canadian public safety workers with depression, anxiety, or PTSD feel better and access mental health support more easily.
-
EMDR combined with gentle brain stimulation (tDCS) for fibromyalgia
This project will test whether adding non-invasive brain stimulation (tDCS) to EMDR helps people with fibromyalgia who also have trauma-related symptoms, depression, or anxiety.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.